Voluntary Cannabinoid Gelatin in Mice Produced Different Pain-Outcome Patterns

Illustration of a printed chromatogram beside a sample vial and pen

Voluntary consumption is a useful experimental feature, but it does not make a mouse treatment study equivalent to human edible use. A gelatin-administration model found sustained cannabinoid effects on some nerve-injury outcomes, with important differences among measurements.

Mice chose when to consume

Male and female mice consumed gelatin containing THC, CBD or morphine over several weeks. Investigators recorded consumption and detected drug exposure in serum. THC-gelatin consumption was lower than consumption in the other reported drug-gelatin groups.

The pain-related outcomes were not identical

All three treatments reduced measures of allodynia in the nerve-injury model. The abstract reports tolerance to morphine after a week, whereas THC and CBD retained effects on allodynia over three weeks. At the final hyperalgesia assessment, THC showed a significant effect, CBD a trend and morphine no effect.

A trend is not the same as a significant result

The different hyperalgesia findings should remain separate from the allodynia results. The investigators also recorded ultrasonic clicks associated with injury that decreased with treatment, proposing another potential research measure. Those vocalizations are not direct human pain ratings.

Self-directed intake introduces a different exposure pattern from fixed injections and complicates simple dose comparisons. Serum detection supports exposure, not proof of impairment or equivalence among treatments. The study offers a way to investigate repeated oral administration in mice without establishing a human cannabis prescription, a long-term clinical benefit or a personal tolerance timetable.

Related: interpreting cannabis tolerance claims.

Research cited

Abraham AD; Leung EJY; Wong BA; Rivera ZMG; Kruse LC; Clark JJ; Land BB. Orally consumed cannabinoids provide long-lasting relief of allodynia in a mouse model of chronic neuropathic pain. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (2020). doi:10.1038/s41386-019-0585-3. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

What Was Randomized in a Survey Comparing Intense Drug Experiences?

The experience being reported was selected through survey-routing procedures. The substance exposure itself was not randomly assigned. That distinction determines what a retrospective comparison can establish. Routing participants to past experiences Chwyl and colleagues’ supplied preprint analyzed 397 adults reporting on intense psilocybin, MDMA or cannabis experiences within the previous…

Spread the love

Read Article: What Was Randomized in a Survey Comparing Intense Drug Experiences?

How Do Naturalistic Human Observations Differ From Mouse Tests of Visual Prediction?

A supplied preprint combined observational human comparisons with controlled mouse experiments. Those evidence streams can inform one another without carrying the same causal weight. Recent use was observed in people West and colleagues compared visual responses in recent psychedelic users and controls. Dose and potency could not be directly established….

Spread the love

Read Article: How Do Naturalistic Human Observations Differ From Mouse Tests of Visual Prediction?

Does a Link Between Psilocybin Use and Nature Relatedness Establish Cause?

A statistical association between past psilocybin use and feeling connected to nature does not establish that taking psilocybin caused that connection. What was compared Forstmann and colleagues reanalyzed five datasets comprising 3,817 participants. Among psychedelic-experienced participants, psilocybin experience was the most reliable substance-use predictor of self-reported nature relatedness. The analyses…

Spread the love

Read Article: Does a Link Between Psilocybin Use and Nature Relatedness Establish Cause?

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us